Eosinophilic Esophagitis Steroid Safety Study

Inclusion Criteria

• •1. Age \<18 years at the time of enrollment.
• •2. Males and Females are included.
• •3. Patients diagnosed with EoE as defined by age appropriate signs of esophageal dysfunction (in older children and adolescents - dysphagia, impacted food bolus, foreign body impaction, vomiting, and GERD not responsive to high dose proton pump inhibitors. In infants and young children - failure to thrive, poor feeding, vomiting, food bolus impaction)
• •4. Histopathological finding of ≥15 eosinophils/high power field (X400) on at least one esophageal biopsy.
• •5. After discussing the available treatment options with the gastroenterologist, the patient has chosen oral topical steroid treatment (either as a first treatment or after failure of other dietary or medical treatment).